|
KALRN expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.160800E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.355000E-04 |
| Normal-vs-Stage2 |
4.198200E-03 |
| Normal-vs-Stage3 |
4.079600E-01 |
| Normal-vs-Stage4 |
4.129200E-01 |
| Stage1-vs-Stage2 |
5.369600E-01 |
| Stage1-vs-Stage3 |
2.769000E-01 |
| Stage1-vs-Stage4 |
9.943600E-01 |
| Stage2-vs-Stage3 |
1.787850E-01 |
| Stage2-vs-Stage4 |
8.230600E-01 |
| Stage3-vs-Stage4 |
5.988400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.578340E-04 |
| Normal-vs-AfricanAmerican |
4.929400E-01 |
| Normal-vs-Asian |
4.857200E-01 |
| Caucasian-vs-AfricanAmerican |
1.034820E-01 |
| Caucasian-vs-Asian |
9.188000E-01 |
| AfricanAmerican-vs-Asian |
6.653800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.01170000000617E-05 |
| Normal-vs-Female |
7.319600E-01 |
| Male-vs-Female |
3.797600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.764600E-01 |
| Normal-vs-Extreme_Weight |
8.17029999211627E-09 |
| Normal-vs-Obese |
3.800300E-02 |
| Normal-vs-Extreme_Obese |
8.031200E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.025190E-01 |
| Normal_Weight-vs-Obese |
7.427000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.214400E-01 |
| Extreme_Weight-vs-Obese |
3.162200E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.135400E-01 |
| Obese-vs-Extreme_Obese |
5.570800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.749000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.494760E-01 |
| Normal-vs-Age(61-80Yrs) |
3.27189997317845E-09 |
| Normal-vs-Age(81-100Yrs) |
9.82560000029054E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.936650E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.799700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.914000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.243440E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.299900E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.298000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.96669999999555E-06 |
| Normal-VS-Type2 PRCC |
1.238300E-02 |
| Normal-VS-KIRP CIMP |
6.738200E-02 |
| Normal-VS-Unclassified PRCC |
8.536000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
9.878000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.531630E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.577200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.858580E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
3.898400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.622630E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.653200E-01 |
| Normal-vs-N1 |
9.317800E-01 |
| Normal-vs-N2 |
8.168200E-01 |
| N0-vs-N1 |
4.303400E-01 |
| N0-vs-N2 |
5.448600E-01 |
| N1-vs-N2 |
8.074600E-01 |
|
|
